|
Kidney donation after cardiac death may expand donor pool, research shows
December 05, 2007WINSTON-SALEM, N.C. - New research at Wake Forest University Baptist Medical Center suggests that transplanting kidneys from donors who died after cardiac arrest - which used to be considered taboo - offers a promising approach to increase the donor pool.
A study found similar short-term results between kidneys donated after cardiac death (DCD) and kidneys donated after brain death, according to senior researcher Robert Stratta, M.D., a professor of surgery. The results were reported today at the annual meeting of the Southern Surgical Association in Hot Springs, Va.
"Despite greater initial resource utilization, comparable short-term results can be achieved with kidneys donated after cardiac death," said Stratta. "This alternative provides an important means of increasing the donor pool."
Originally, all transplanted organs came either from donors who died after cardiac death (so-called non-heartbeating donors) or from living donors. That changed in the 1970s because of new laws defining death as a lack of brain activity. In addition to brain death becoming the standard definition of death for organ donation, DCD organs were no longer used because of the possibility of damage to the kidneys when they were deprived of blood and oxygen.
Because of the current shortage of donated organs, experts in the field are working to make more effective use of organs that are available. In the last decade, median waiting times for kidney transplantation have doubled, and the kidney waiting list has increased nearly threefold. There are currently 78,000 people are on the waiting list for kidney transplantation in the United States. In 2006, only 24 percent of them received transplants.
There is now renewed interest in DCD organs, and transplant centers across the country are beginning to use them. From 2005 to 2006, a 16 percent increase occurred in DCD donors, from 560 to 647 donors. These organs are donated by families who decide to withdraw life support when patients have severe irreversible brain injury and no chance for meaningful recovery. These patients do not meet the criteria for brain death, and will experience cardiac arrest when life support is withdrawn.
Organ recovery occurs only after a declaration of death based on complete cessation of heart activity for a specific period of time. While the use of these organs is becoming more common, it represents less than 10 percent of deceased donor transplant activity in the United States.
The current study involved 53 kidney transplants and four transplants of both a kidney and pancreas that all involved organs donated after cardiac death. The transplants occurred between April 2003 and October 2007. After donation, all kidneys were placed on a pump to resuscitate them and preserve their function. With a mean follow-up of 12 months, survival rates were 95 percent for patients, 88 percent for kidneys, and 100 percent for pancreata that were transplanted.
The researchers compared results of these DCD transplants with 316 transplants involving kidneys donated after brain death that occurred during the same study period. There were no differences in patient survival or survival of the transplanted organs, although one-year kidney function for DCD donor kidneys was intermediate between standard criteria (younger) and expanded criteria (older) brain-dead donors.
Also, in over half (57 percent) of the transplants involving DCD organs, there was delayed graft function, which meant that the recipient required temporary dialysis to support the transplanted kidney before it began functioning on its own. These organs also had higher rates (19 percent versus 10 percent) of acute rejection, which is when the body shows early signs of rejecting the transplanted kidney. These complications resulted in longer hospital stays (11 days for DCD transplants versus 8 days for transplants involved organs donated after brain death.) However, delayed graft function did not result in a higher rate of graft failure as virtually all of these DCD donor kidneys recovered adequately to provide life-sustaining function.
Further study also suggests that the use of extracorporeal support after cardiac arrest and declaration of death, which pumps oxygenated blood throughout the body, may offer an innovative way to reduce delayed graft function and improve organ recovery in DCD donors. In cases where life support is being withdrawn and the family wants to donate organs, the technology is implemented immediately after the patient is declared dead.
In a comparison of 10 kidneys recovered with extracorporal support versus 47 kidneys recovered without the support, rates of delayed draft function were reduced from 60 percent to 20 percent. Moreover, extracorporeal support permitted the use of other organs for transplantation, such as the liver and pancreas.
Wake Forest University Baptist Medical Center
Originally, all transplanted organs came either from donors who died after cardiac death (so-called non-heartbeating donors) or from living donors. That changed in the 1970s because of new laws defining death as a lack of brain activity. In addition to brain death becoming the standard definition of death for organ donation, DCD organs were no longer used because of the possibility of damage to the kidneys when they were deprived of blood and oxygen.
Because of the current shortage of donated organs, experts in the field are working to make more effective use of organs that are available. In the last decade, median waiting times for kidney transplantation have doubled, and the kidney waiting list has increased nearly threefold. There are currently 78,000 people are on the waiting list for kidney transplantation in the United States. In 2006, only 24 percent of them received transplants.
There is now renewed interest in DCD organs, and transplant centers across the country are beginning to use them. From 2005 to 2006, a 16 percent increase occurred in DCD donors, from 560 to 647 donors. These organs are donated by families who decide to withdraw life support when patients have severe irreversible brain injury and no chance for meaningful recovery. These patients do not meet the criteria for brain death, and will experience cardiac arrest when life support is withdrawn.
Organ recovery occurs only after a declaration of death based on complete cessation of heart activity for a specific period of time. While the use of these organs is becoming more common, it represents less than 10 percent of deceased donor transplant activity in the United States.
The current study involved 53 kidney transplants and four transplants of both a kidney and pancreas that all involved organs donated after cardiac death. The transplants occurred between April 2003 and October 2007. After donation, all kidneys were placed on a pump to resuscitate them and preserve their function. With a mean follow-up of 12 months, survival rates were 95 percent for patients, 88 percent for kidneys, and 100 percent for pancreata that were transplanted.
The researchers compared results of these DCD transplants with 316 transplants involving kidneys donated after brain death that occurred during the same study period. There were no differences in patient survival or survival of the transplanted organs, although one-year kidney function for DCD donor kidneys was intermediate between standard criteria (younger) and expanded criteria (older) brain-dead donors.
Also, in over half (57 percent) of the transplants involving DCD organs, there was delayed graft function, which meant that the recipient required temporary dialysis to support the transplanted kidney before it began functioning on its own. These organs also had higher rates (19 percent versus 10 percent) of acute rejection, which is when the body shows early signs of rejecting the transplanted kidney. These complications resulted in longer hospital stays (11 days for DCD transplants versus 8 days for transplants involved organs donated after brain death.) However, delayed graft function did not result in a higher rate of graft failure as virtually all of these DCD donor kidneys recovered adequately to provide life-sustaining function.
Further study also suggests that the use of extracorporeal support after cardiac arrest and declaration of death, which pumps oxygenated blood throughout the body, may offer an innovative way to reduce delayed graft function and improve organ recovery in DCD donors. In cases where life support is being withdrawn and the family wants to donate organs, the technology is implemented immediately after the patient is declared dead.
In a comparison of 10 kidneys recovered with extracorporal support versus 47 kidneys recovered without the support, rates of delayed draft function were reduced from 60 percent to 20 percent. Moreover, extracorporeal support permitted the use of other organs for transplantation, such as the liver and pancreas.
Wake Forest University Baptist Medical Center
Cardiac Death News and Current Cardiac Death Events RSSNew system devised to guide doctors treating patients with symptomatic myocardial bridging
What type of intervention, if any, should cardiologists offer their patients who have a heart abnormality called myocardial bridging and symptoms of heart problems?
Children with ADHD should get heart tests before treatment with stimulant drugs
Children with attention deficit hyperactivity disorder (ADHD) should get careful cardiac evaluation and monitoring - including an electrocardiogram (ECG) - before treatment with stimulant drugs, a new American Heart Association statement recommends.
Genetic variants of USF1 are associated with the increased risk for cardiovascular disease
Cardiovascular diseases (CVD) are major contributors to morbidity and mortality worldwide. Several interacting environmental, biochemical, and genetic risk factors can increase disease susceptibility.
Malfunctioning kidneys may raise risk of sudden death in women
Women whose kidneys are poor at filtering impurities from the blood are at heightened risk of sudden cardiac death, according to a report published in Hypertension: Journal of the American Heart Association.
Angina drug potentially useful against heart rhythm disorders
A recently approved angina drug may also represent a powerful new treatment for a rare hereditary syndrome that places teens at risk for sudden cardiac death, according to research presented to today at the 57th Annual Scientific Sessions of the American College of Cardiology (ACC) in Chicago.
Heart failure treated 'in the brain'
Beta-blockers heal the heart via the brain when administered during heart failure, according to a new study by UCL (University College London).
Study verifies that cholesterol-associated gene variants can predict cardiovascular events
A study appearing in this week's New England Journal of Medicine confirms that a combination of gene variants previously associated with cholesterol levels does reflect patients' cholesterol levels and can signify increased risk of heart attack, stroke or sudden cardiac death.
The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent
Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.
Implantable medical devices may expose patients to security, privacy risks; solutions suggested
Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits. But this convenience may come with unanticipated risks.
Johns Hopkins to participate in 1000 Genomes Project
Researchers at the McKusick-Nathans Institute of Genetic Medicine (IGM) at Johns Hopkins will join other national and international scientists in the 1000 Genomes Project, an ambitious effort that will involve sequencing the genomes of numerous people from around the world to create the most detailed and medically useful picture to date of human genetic variation.
More Cardiac Death News Articles
 | terrO.R. by Joseph J. Neuschatz |
 | Pathology of the Heart and Sudden Death in Forensic Medicine by Vittorio Fineschi, Giorgio Baroldi, Malcolm D. Silver |
 | Pathology of Sudden Cardiac Death: An Illustrated Guide by Brooks S., MD Edwards, Jesse E., MD Edwards |
 | Sudden Death and the Myth of CPR by Stefan Timmermans, Bern Shen |
 | One Beat at a Time - Living with Sudden Cardiac Death by Matthew D. Noble |
 | Sudden Cardiac Death in the Athlete |
 | Ventricular Arrhythmias and Sudden Cardiac Death |
 | Sudden Cardiac Death: A Handbook for Clinical Practice (European Society of Cardiology) |
 | Arrhythmias and Sudden Death in Athletes (Developments in Cardiovascular Medicine) |
 | Enigma of Sudden Cardiac Death: Blend Of Garments and Sudden Cardiac Death by A Rashid Seyal |
| © 2008 BrightSurf.com |